Literature DB >> 17698679

Institutional review boards should require clinical trial registration.

Leonard A Levin1, Julie Gage Palmer.   

Abstract

Mesh：

Year:  2007        PMID： 17698679     DOI： 10.1001/archinte.167.15.1576

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  6 in total

1.  Medicine. Moving toward transparency of clinical trials.

Authors:  Deborah A Zarin; Tony Tse
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

2.  Peer Reviewed Evaluation of Registered End-Points of Randomised Trials (the PRE-REPORT study): a stepped wedge, cluster-randomised trial.

Authors:  Christopher W Jones; Amanda Adams; Benjamin S Misemer; Mark A Weaver; Sara Schroter; Hayat Khan; Benyamin Margolis; David L Schriger; Timothy F Platts-Mills
Journal:  BMJ Open       Date:  2022-09-28       Impact factor: 3.006

3.  Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Authors:  Nicolas Rasmussen; Kirby Lee; Lisa Bero
Journal:  Trials       Date:  2009-12-16       Impact factor: 2.279

4.  Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data.

Authors:  Daniel Strech; Jasper Littmann
Journal:  Trials       Date:  2012-07-02       Impact factor: 2.279

5.  How psychiatry journals support the unbiased translation of clinical research. A cross-sectional study of editorial policies.

Authors:  Hannes Knüppel; Courtney Metz; Joerg J Meerpohl; Daniel Strech
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 6.  Non-publication of large randomized clinical trials: cross sectional analysis.

Authors:  Christopher W Jones; Lara Handler; Karen E Crowell; Lukas G Keil; Mark A Weaver; Timothy F Platts-Mills
Journal:  BMJ       Date:  2013-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.